Cogent Biosciences stockholders approve 6M share increase under 2018 Equity Plan

Cogent Biosciences, Inc.

All three director nominees elected: Chris Cain, Arlene Morris, Todd Shegog each received >51% of votes cast.
Proposal to increase shares reserved under 2018 Stock Option Plan by 6,000,000 shares passed with 40,805,846 for, 23,427,202 against.
Ratification of PricewaterhouseCoopers as independent auditor approved with 65,536,975 votes for, 26,688 against.
Record date April 10, 2023: 70,946,790 shares entitled to vote.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Cogent Biosciences, Inc. shareholders approved Ratification of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm.

Proposal: auditor ratification
Outcome: passed

Exact text from the filing

Proposal 3. Ratification of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm 65,536,975 26,688 2,800 0

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Cogent Biosciences, Inc. shareholders approved Election of Directors.

Proposal: director election
Outcome: passed

Exact text from the filing

Proposal 1. Election of Directors • Chris Cain, Ph.D. 52,182,072 12,054,821 1,329,570 • Arlene M. Morris 51,995,228 12,241,665 1,329,570 • Todd Shegog 51,200,110 13,036,783 1,329,570

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Cogent Biosciences, Inc. shareholders approved Approval of an increase of 6,000,000 shares reserved for issuance under the 2018 Plan.

Proposal: equity plan
Outcome: passed

Exact text from the filing

Proposal 2. Approval of an increase of 6,000,000 shares reserved for issuance under the 2018 Plan 40,805,846 23,427,202 3,845 1,329,570

View on SEC.gov

Browse all shareholder votes →

Cogent Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-162557

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.